Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff; C. Rummelt; H. Menzel; M. Sigl; C. Peschel; J. Duyster

doi:10.1038/leu.2010.122

Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff^*, C. Rummelt, H. Menzel, M. Sigl, C. Peschel, J. Duyster

^*Corresponding author for this work

Clinic of Hematology and Oncology

Technical University of Munich

18 Citations (Scopus)

Original language	English
Journal	Leukemia
Volume	24
Issue number	8
Pages (from-to)	1523-1525
Number of pages	3
ISSN	0887-6924
DOIs	https://doi.org/10.1038/leu.2010.122
Publication status	Published - 08.2010

Funding

Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer (équipe labelisée 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. This work was supported by Bundesministerium für Bildung und Forschung grant NGFNplus 01GS0878.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2010.122

Cite this

@article{d3ff5aee767242d08cb349778599a344,

title = "Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib",

author = "\{Von Bubnoff\}, N. and C. Rummelt and H. Menzel and M. Sigl and C. Peschel and J. Duyster",

note = "Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer ({\'e}quipe labelis{\'e}e 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium f{\"u}r Bildung und Forschung grant NGFNplus 01GS0878.",

year = "2010",

month = aug,

doi = "10.1038/leu.2010.122",

language = "English",

volume = "24",

pages = "1523--1525",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

AU - Von Bubnoff, N.

AU - Rummelt, C.

AU - Menzel, H.

AU - Sigl, M.

AU - Peschel, C.

AU - Duyster, J.

N1 - Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer (équipe labelisée 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium für Bildung und Forschung grant NGFNplus 01GS0878.

PY - 2010/8

Y1 - 2010/8

UR - https://www.scopus.com/pages/publications/77955710421

U2 - 10.1038/leu.2010.122

DO - 10.1038/leu.2010.122

M3 - Letters

C2 - 20520641

AN - SCOPUS:77955710421

SN - 0887-6924

VL - 24

SP - 1523

EP - 1525

JO - Leukemia

JF - Leukemia

IS - 8

ER -

Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

Funding

UN SDGs

Access to Document

Other files and links

Cite this